A pre-earnings briefing just rewrote the investment case for China's most beaten-down mega-cap.
Category: Top News
Exxon vs. Chevron. One Reports July 24. One Reports July 31.
Both energy giants beat in Q1. The Q2 call is where the real story gets told.
The Only Number That Tells You If a Business Is Actually Any Good
ROIC separates the compounders from the capital destroyers.
Cameco Is Down From Its High. The Nuclear Trade Has Never Been Bigger.
AI's power problem just became uranium's biggest catalyst in decades.
SpaceX Joins the Nasdaq-100 in Two Days. The Forced Buying Is Already Priced In.
What happens to SPCX after the mechanical flow ends is the only question that matters now.
Europe’s Defense Boom Is Hitting a Wall
The spending is real. The question now is whether the companies can actually deliver.
Big Pharma Has $1.3 Trillion to Spend. The Clock Is Running.
A patent cliff with a known deadline is forcing the largest acquisition wave in biopharma history.
Bending Spoons Is Now Public. The Story Has 1,000 Chapters Left.
An Italian software roll-up just had one of the year's best IPO debuts.
Vertiv Is Up 73% in 2026. Now Comes the Hard Part.
Q2 earnings are *estimated* for July 29. The backlog is massive. The valuation is not cheap.
Rocket Lab Just Changed the Space Economy Overnight
An $8 billion Iridium deal turns RKLB into a vertically integrated satellite powerhouse.